Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 21.35B | 18.29B | 17.53B | 8.55B | 4.67B |
Gross Profit | 2.98B | 2.20B | 3.72B | -2.45B | -5.94B |
EBITDA | 3.20B | 2.18B | 4.18B | -2.02B | -6.26B |
Net Income | 2.04B | 835.69M | 3.22B | -3.26B | -7.52B |
Balance Sheet | |||||
Total Assets | 33.57B | 33.07B | 35.71B | 32.23B | 27.02B |
Cash, Cash Equivalents and Short-Term Investments | 5.97B | 6.47B | 9.00B | 4.88B | 2.83B |
Total Debt | 20.69B | 22.84B | 26.14B | 26.28B | 17.58B |
Total Liabilities | 24.10B | 25.53B | 29.10B | 28.86B | 20.42B |
Stockholders Equity | 9.47B | 7.54B | 6.61B | 3.36B | 6.60B |
Cash Flow | |||||
Free Cash Flow | 1.94B | 1.00B | 4.18B | -2.89B | -7.88B |
Operating Cash Flow | 3.37B | 2.04B | 5.03B | -2.67B | -6.73B |
Investing Cash Flow | -1.55B | -1.07B | -767.39M | -306.57M | -816.48M |
Financing Cash Flow | -2.32B | -3.50B | -143.28M | 5.02B | 7.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥22.48B | 8.30 | 1.29% | 10.08% | 15.90% | ||
72 Outperform | ¥19.53B | 7.31 | 1.49% | 20.01% | 290.10% | ||
70 Neutral | ¥7.77B | 9.42 | 0.47% | 3.63% | -7.07% | ||
67 Neutral | ¥277.48B | 14.88 | 6.81% | 2.50% | 5.07% | -22.68% | |
61 Neutral | ¥15.72B | 6.63 | 0.49% | 28.56% | 213.63% | ||
58 Neutral | ¥17.78B | 72.51 | 6.59% | ― | 17.45% | 664.98% | |
57 Neutral | ¥7.95B | 27.72 | 0.38% | 9.47% | -57.17% |